{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:58:45Z","timestamp":1785265125479,"version":"3.55.0"},"reference-count":38,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62272468"],"award-info":[{"award-number":["62272468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Basic Research Program of Shaanxi","award":["2023-JC-QN-0910"],"award-info":[{"award-number":["2023-JC-QN-0910"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,6,12]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify the predictors of renal relapse in patients with lupus nephritis (LN) and develop a predictive model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The patients with LN who received renal biopsies from 2005 to 2024 in Xijing Hospital were enrolled. This study was designed as a cohort study. Clinical and serological characteristics at the time of renal biopsy, nephritis histology, the duration to remission and treatment regimen were evaluated. Variables were screened using least absolute shrinkage and selection operator (LASSO)-Cox analyses, followed by the application of multivariate Cox regression to construct a relapse risk prediction model. The performance of the model was evaluated using bootstrap resampling. A landmark analysis was performed at 12 months, excluding patients who relapsed within this period. The model is intended for application at the 12-month postbiopsy time point.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 831 patients were enrolled in the study, 225\/831 patients (27.08%) experienced relapse. Compared with the patients without relapse, patients with relapse demonstrated younger age of onset (24.0 vs 27.0 years, p=0.001), higher SLE Disease Activity Index (SLEDAI) (12.0 vs 7.0, p=0.001) and proteinuria (1.2 vs 0.6\u2009g\/day, p=0.001). However, the nephritis histology showed no significant difference between the two groups. The proportion of patients receiving intravenous methylprednisolone pulse therapy or belimumab in the non-relapse group was significantly higher. Using LASSO-Cox regression, four variables associated with LN relapse were identified, including level of 24-hour proteinuria, SLEDAI 2000 (SLEDAI-2K), low complement C3 level and remission within 12 months. The predictive model exhibited good predictive performance, with a bootstrap-corrected C-index of 0.75 (95% CI 0.72 to 0.79).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher level of 24-hour proteinuria, higher SLEDAI-2K score and low complement C3 level were risk factors for LN relapse, while remission within 12 months was a protective factor. The LASSO-Cox-based predictive model exhibited good performance and may serve as a useful tool for the clinical management of LN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2026-002003","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:10:20Z","timestamp":1782396620000},"page":"e002003","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a LASSO-based machine learning model for relapse prediction in lupus nephritis"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4079-6719","authenticated-orcid":false,"given":"Hao","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-6063","authenticated-orcid":false,"given":"Jin","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-0406","authenticated-orcid":false,"given":"Zhaohui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"2026072811152552000_13.1.e002003.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01277-y"},{"key":"2026072811152552000_13.1.e002003.2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/art.42941","article-title":"Association of Autoantibody Concentrations and Trajectories With Lupus Nephritis Histologic Features and Treatment Response","volume":"76","author":"Fava","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026072811152552000_13.1.e002003.3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/key260","article-title":"Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome","volume":"58","author":"Wester Trejo","year":"2019","journal-title":"Rheumatology"},{"key":"2026072811152552000_13.1.e002003.4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11926-023-01109-6","article-title":"Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention","volume":"25","author":"Banos","year":"2023","journal-title":"Curr Rheumatol Rep"},{"key":"2026072811152552000_13.1.e002003.5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1177\/0961203317716320","article-title":"Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience","volume":"26","author":"Momtaz","year":"2017","journal-title":"Lupus"},{"key":"2026072811152552000_13.1.e002003.6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170226"},{"key":"2026072811152552000_13.1.e002003.7","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/rheumatology\/keaa599","article-title":"Life prognosis and renal relapse after induction therapy in Japanese patients with proliferative and pure membranous lupus nephritis","volume":"60","author":"Okamoto","year":"2021","journal-title":"Rheumatology"},{"key":"2026072811152552000_13.1.e002003.8","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001264","article-title":"Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort","volume":"11","author":"Urowitz","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026072811152552000_13.1.e002003.9","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1093\/rheumatology\/keaf194","article-title":"Histologic predictors of kidney outcomes in LN: re-evaluating the role of segmental glomerulosclerosis in the chronicity index","volume":"64","author":"Tinajero-S\u00e1nchez","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026072811152552000_13.1.e002003.10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/art.42725","article-title":"Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood-Onset Proliferative Lupus Nephritis","volume":"76","author":"Wang","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026072811152552000_13.1.e002003.11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41584-023-01058-5","article-title":"Shifting the SLE management paradigm: challenges and implications","volume":"20","author":"Koopman","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"2026072811152552000_13.1.e002003.12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/ndt\/gfad191","article-title":"A nomogram predicting the histologic activity of lupus nephritis from clinical parameters","volume":"39","author":"Gao","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026072811152552000_13.1.e002003.13","doi-asserted-by":"crossref","first-page":"110296","DOI":"10.1016\/j.clim.2024.110296","article-title":"A nomogram to predict the risk of proliferative lupus nephritis in patients with systemic lupus erythematosus involving the kidneys","volume":"265","author":"Yang","year":"2024","journal-title":"Clin Immunol"},{"key":"2026072811152552000_13.1.e002003.14","doi-asserted-by":"crossref","unstructured":"Yang P , Liu Z , Lu F , et al . Machine learning models predicts risk of proliferative lupus nephritis. Front Immunol 2024;15. doi:10.3389\/fimmu.2024.1413569","DOI":"10.3389\/fimmu.2024.1413569"},{"key":"2026072811152552000_13.1.e002003.15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/rheumatology\/keae381","article-title":"Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes","volume":"64","author":"Panagiotopoulos","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026072811152552000_13.1.e002003.16","doi-asserted-by":"crossref","unstructured":"Kim S , Choi YE , Kim SG , et al . Clinical features and outcomes of immune complex-membranoproliferative glomerulonephritis and C3 glomerulopathy: a multicenter observational cohort study analyzing kidney biopsy cases. Kidney Res Clin Pract 2024. doi:10.23876\/j.krcp.24.129","DOI":"10.23876\/j.krcp.24.129"},{"key":"2026072811152552000_13.1.e002003.17","doi-asserted-by":"crossref","first-page":"105756","DOI":"10.1016\/j.jbspin.2024.105756","article-title":"Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal","volume":"91","author":"Trefond","year":"2024","journal-title":"Joint Bone Spine"},{"key":"2026072811152552000_13.1.e002003.18","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1093\/rheumatology\/keab126","article-title":"Early predictors of renal outcome in patients with proliferative lupus nephritis: a 36-month cohort study","volume":"60","author":"Lu\u00eds","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026072811152552000_13.1.e002003.19","doi-asserted-by":"publisher","DOI":"10.1159\/000513566"},{"key":"2026072811152552000_13.1.e002003.20","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2026072811152552000_13.1.e002003.21","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026072811152552000_13.1.e002003.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00443.x"},{"key":"2026072811152552000_13.1.e002003.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023"},{"key":"2026072811152552000_13.1.e002003.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.002"},{"key":"2026072811152552000_13.1.e002003.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.05.021"},{"key":"2026072811152552000_13.1.e002003.26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ard.2025.09.007","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update","volume":"85","author":"Fanouriakis","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"2026072811152552000_13.1.e002003.27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/rheumatology\/keae023","article-title":"Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab","volume":"64","author":"J\u00e4gerback","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026072811152552000_13.1.e002003.28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/kead447","article-title":"Renal relapse in children and adolescents with childhood-onset lupus nephritis: a 20-year study","volume":"63","author":"Chan","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026072811152552000_13.1.e002003.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045934","article-title":"Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study","volume":"7","author":"Conti","year":"2012","journal-title":"PLoS One"},{"key":"2026072811152552000_13.1.e002003.30","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000389","article-title":"Prediction of prognosis and renal outcome in lupus nephritis","volume":"7","author":"Parodis","year":"2020","journal-title":"Lupus Sci Med"},{"key":"2026072811152552000_13.1.e002003.31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215089"},{"key":"2026072811152552000_13.1.e002003.32","doi-asserted-by":"crossref","unstructured":"Boneparth A , Davidson A . B-cell activating factor targeted therapy and lupus. Arthritis Res Ther 2012;14 Suppl 4. doi:10.1186\/ar3920","DOI":"10.1186\/ar3920"},{"key":"2026072811152552000_13.1.e002003.33","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2395451","article-title":"Efficacy and safety of biologics, multitarget therapy, and standard therapy for lupus nephritis: a systematic review and network meta-analysis","volume":"46","author":"Tian","year":"2024","journal-title":"Ren Fail"},{"key":"2026072811152552000_13.1.e002003.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180"},{"key":"2026072811152552000_13.1.e002003.35","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02520322"},{"key":"2026072811152552000_13.1.e002003.36","doi-asserted-by":"crossref","unstructured":"Hou J , Liang D , Quan S , et al . Predictive value of residual active histologic lesions on renal flare in lupus nephritis patients with clinical remission. Clin Kidney J 2024;17. doi:10.1093\/ckj\/sfae350","DOI":"10.1093\/ckj\/sfae350"},{"key":"2026072811152552000_13.1.e002003.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-071821","article-title":"Deep learning model to predict lupus nephritis renal flare based on dynamic multivariable time-series data","volume":"14","author":"Huang","year":"2024","journal-title":"BMJ Open"},{"key":"2026072811152552000_13.1.e002003.38","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001375","article-title":"Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis","volume":"12","author":"Vidal-Montal","year":"2025","journal-title":"Lupus Sci Med"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2026-002003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:15:34Z","timestamp":1785262534000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2026-002003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,25]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/lupus-2026-002003"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2026-002003","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}